Join to View Full Profile
Department of Radiation OncologyUniversity of Texas MD Anderson Cancer CenterHouston, TX 77030
Dr. Hassanzadeh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Missouri Kansas City School of MedicineClass of 2017
Certifications & Licensure
FL State Medical License 2023 - Present
WA State Medical License 2023 - 2026
AL State Medical License 2023 - 2025
AZ State Medical License 2023 - 2025
GA State Medical License 2023 - 2025
LA State Medical License 2023 - 2025
MS State Medical License 2023 - 2025
American Board of Radiology Radiation Oncology- Join now to see all
Publications & Presentations
PubMed
- Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium.Amar U Kishan, Yilun Sun, Alison C Tree, Emma Hall, David Dearnaley
The Lancet. Oncology. 2025-04-01 - Safety and early outcomes of proton therapy and low-dose rate brachytherapy boost for patients with prostate cancer.Osama Mohamad, Zakaria El Kouzi, Ramez Kouzy, Seungtaek Choi, Henry Mok
Brachytherapy. 2025-03-02 - Early outcomes following local salvage treatment with MRI-assisted low-dose rate brachytherapy (MARS) for MRI-visible postsurgical bed recurrences and focal intraprost...Comron Hassanzadeh, Osama Mohamad, Teresa Bruno, Lin Wang, Rajat Kudchakar
Brachytherapy. 2025-01-03
Press Mentions
Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer: What to KnowMarch 5th, 2025- MD Anderson Research Highlights Special Edition: ASTRO 2024September 27th, 2024
- ASTRO 2024: Hypofractionated, Dose-Escalated Radiation vs. Conventionally Fractionated Radiation for Localized Prostate Cancer: Long-Term Update of a Phase 3, Prospective, Randomized Controlled TrialFebruary 19th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
